159 related articles for article (PubMed ID: 9618539)
1. Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein.
Snitkovsky S; Young JA
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7063-8. PubMed ID: 9618539
[TBL] [Abstract][Full Text] [Related]
2. Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein.
Snitkovsky S; Niederman TM; Mulligan RC; Young JA
J Virol; 2001 Feb; 75(3):1571-5. PubMed ID: 11152532
[TBL] [Abstract][Full Text] [Related]
3. A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor.
Snitkovsky S; Niederman TM; Carter BS; Mulligan RC; Young JA
J Virol; 2000 Oct; 74(20):9540-5. PubMed ID: 11000224
[TBL] [Abstract][Full Text] [Related]
4. Soluble forms of the subgroup A avian leukosis virus [ALV(A)] receptor Tva significantly inhibit ALV(A) infection in vitro and in vivo.
Holmen SL; Salter DW; Payne WS; Dodgson JB; Hughes SH; Federspiel MJ
J Virol; 1999 Dec; 73(12):10051-60. PubMed ID: 10559319
[TBL] [Abstract][Full Text] [Related]
5. The Novel Avian Leukosis Virus Subgroup K Shares Its Cellular Receptor with Subgroup A.
Přikryl D; Plachý J; Kučerová D; Koslová A; Reinišová M; Šenigl F; Hejnar J
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217247
[TBL] [Abstract][Full Text] [Related]
6. Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.
Holmen SL; Melder DC; Federspiel MJ
J Virol; 2001 Jan; 75(2):726-37. PubMed ID: 11134286
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the subgroup A avian sarcoma and leukosis virus receptor: the 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry.
Rong L; Bates P
J Virol; 1995 Aug; 69(8):4847-53. PubMed ID: 7609052
[TBL] [Abstract][Full Text] [Related]
8. Residues L55 and W69 of Tva Mediate Entry of Subgroup A Avian Leukosis Virus.
Chen Y; Wang S; Li X; Yu M; Liu P; Meng L; Guo R; Feng X; Liu A; Qi X; Li K; Gao L; Pan Q; Zhang Y; Liu C; Cui H; Wang X; Gao Y
J Virol; 2022 Sep; 96(18):e0067822. PubMed ID: 36069550
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.
Melder DC; Pankratz VS; Federspiel MJ
J Virol; 2003 Oct; 77(19):10504-14. PubMed ID: 12970435
[TBL] [Abstract][Full Text] [Related]
10. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
Melder DC; Pike GM; VanBrocklin MW; Federspiel MJ
J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
[TBL] [Abstract][Full Text] [Related]
11. Identification of a cellular receptor for subgroup E avian leukosis virus.
Adkins HB; Brojatsch J; Naughton J; Rolls MM; Pesola JM; Young JA
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11617-22. PubMed ID: 9326659
[TBL] [Abstract][Full Text] [Related]
12. Characterization of determinants for envelope binding and infection in tva, the subgroup A avian sarcoma and leukosis virus receptor.
Rong L; Gendron K; Strohl B; Shenoy R; Wool-Lewis RJ; Bates P
J Virol; 1998 Jun; 72(6):4552-9. PubMed ID: 9573218
[TBL] [Abstract][Full Text] [Related]
13. Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein.
Snitkovsky S; Young JA
Virology; 2002 Jan; 292(1):150-5. PubMed ID: 11878917
[TBL] [Abstract][Full Text] [Related]
14. Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses.
Zingler K; Young JA
J Virol; 1996 Nov; 70(11):7510-6. PubMed ID: 8892869
[TBL] [Abstract][Full Text] [Related]
15. Residues E53, L55, H59, and G70 of the cellular receptor protein Tva mediate cell binding and entry of the novel subgroup K avian leukosis virus.
Li X; Chen Y; Yu M; Wang S; Liu P; Meng L; Guo R; Feng X; Hu M; He T; Qi X; Li K; Gao L; Zhang Y; Liu C; Cui H; Wang X; Gao Y
J Biol Chem; 2023 Mar; 299(3):102962. PubMed ID: 36717079
[TBL] [Abstract][Full Text] [Related]
16. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
Ochsenbauer-Jambor C; Delos SE; Accavitti MA; White JM; Hunter E
J Virol; 2002 Aug; 76(15):7518-27. PubMed ID: 12097564
[TBL] [Abstract][Full Text] [Related]
17. Two different molecular defects in the Tva receptor gene explain the resistance of two tvar lines of chickens to infection by subgroup A avian sarcoma and leukosis viruses.
Elleder D; Melder DC; Trejbalova K; Svoboda J; Federspiel MJ
J Virol; 2004 Dec; 78(24):13489-500. PubMed ID: 15564460
[TBL] [Abstract][Full Text] [Related]
18. Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types.
Boerger AL; Snitkovsky S; Young JA
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9867-72. PubMed ID: 10449786
[TBL] [Abstract][Full Text] [Related]
19. The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein.
Gilbert JM; Bates P; Varmus HE; White JM
J Virol; 1994 Sep; 68(9):5623-8. PubMed ID: 8057442
[TBL] [Abstract][Full Text] [Related]
20. The spacing between cysteines two and three of the LDL-A module of Tva is important for subgroup A avian sarcoma and leukosis virus entry.
Rai T; Marble D; Rihani K; Rong L
J Virol; 2004 Jan; 78(2):683-91. PubMed ID: 14694099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
